Education
About Us
Working with TipRanks
Follow Us
Renishaw PLC (RNSHF)
OTHER OTC:RNSHF
Cerebral Dopamine Neurotrophic Factor, Renishaw Drug Delivery System
Brain Diseases, Nervous System Diseases, Parkinson Disease, Movement Disorders, Neuro-Degenerative Disease
Phase I/II
Completed
Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study
Oct 11, 2018
―
Cerebral Dopamine Neurotrophic Factor, Renishaw Drug Delivery System
Brain Diseases, Nervous System Diseases, Neurodegenerative Diseases, Parkinson Disease, Movement Disorders
Phase I/II
Completed
Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
Sep 14, 2017
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Renishaw PLC (RNSHF) have in its pipeline
RNSHF is currently developing the following drugs: Cerebral Dopamine Neurotrophic Factor, Renishaw Drug Delivery System, Cerebral Dopamine Neurotrophic Factor, Renishaw Drug Delivery System. These drug candidates are in various stages of clinical development as the company works toward FDA approval.